Solarvest Bioenergy Inc
XTSX:SVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Solarvest Bioenergy Inc
XTSX:SVS
|
CA |
|
V
|
Veradermics Inc
NYSE:MANE
|
US |
|
W
|
Wave Electronics Co Ltd
KOSDAQ:095270
|
KR |
Income Statement
Earnings Waterfall
Solarvest Bioenergy Inc
Income Statement
Solarvest Bioenergy Inc
| Jan-2020 | Apr-2020 | Jul-2020 | Oct-2020 | Jan-2021 | Apr-2021 | Jul-2021 | Oct-2021 | Jan-2022 | Apr-2022 | Jul-2022 | Oct-2022 | Jan-2023 | Apr-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+15%
|
0
-81%
|
0
+8%
|
0
+11%
|
0
+3 963%
|
0
-99%
|
0
+10 117%
|
0
0%
|
0
-98%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-45%
|
0
+27%
|
0
+21%
|
(0)
N/A
|
(0)
+100%
|
(0)
-22 903%
|
(0)
+0%
|
0
N/A
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Research & Development |
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(1)
N/A
|
(2)
-31%
|
(1)
+8%
|
(1)
+9%
|
(2)
-16%
|
(2)
-22%
|
(2)
-26%
|
(3)
-15%
|
(3)
+6%
|
(2)
+10%
|
(2)
+34%
|
(3)
-83%
|
(3)
-2%
|
(3)
-9%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(1)
|
(3)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(2)
-61%
|
(2)
+24%
|
(3)
-76%
|
(4)
-42%
|
(4)
+2%
|
(3)
+9%
|
(4)
-11%
|
(3)
+29%
|
(3)
+8%
|
(2)
+35%
|
(3)
-82%
|
(3)
-4%
|
(3)
-9%
|
|
| Net Income | |||||||||||||||
| Income from Continuing Operations |
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(4)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(3)
|
|
| Net Income (Common) |
(1)
N/A
|
(2)
-61%
|
(2)
+24%
|
(3)
-76%
|
(4)
-42%
|
(4)
+2%
|
(3)
+9%
|
(4)
-11%
|
(3)
+29%
|
(3)
+8%
|
(2)
+35%
|
(3)
-82%
|
(3)
-4%
|
(3)
-9%
|
|
| EPS (Diluted) |
-0.04
N/A
|
-0.06
-50%
|
-0.04
+33%
|
-0.06
-50%
|
-0.08
-33%
|
-0.08
N/A
|
-0.07
+12%
|
-0.06
+14%
|
-0.04
+33%
|
-0.04
N/A
|
-0.03
+25%
|
-0.05
-67%
|
-0.06
-20%
|
-0.06
N/A
|
|